Zacks Research Estimates Nutrien's Q2 Earnings (NYSE:NTR)

Nutrien Ltd. (NYSE:NTR - Free Report) - Investment analysts at Zacks Research raised their Q2 2025 earnings estimates for shares of Nutrien in a report released on Tuesday, June 24th. Zacks Research analyst R. Department now anticipates that the company will earn $2.26 per share for the quarter, up from their prior forecast of $2.25. The consensus estimate for Nutrien's current full-year earnings is $3.72 per share. Zacks Research also issued estimates for Nutrien's Q3 2025 earnings at $0.31 EPS, Q1 2026 earnings at $0.30 EPS, Q2 2026 earnings at $1.24 EPS, Q3 2026 earnings at $0.89 EPS, Q4 2026 earnings at $1.01 EPS, FY2026 earnings at $3.44 EPS, Q1 2027 earnings at $0.62 EPS and FY2027 earnings at $3.60 EPS.

Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.35 by ($0.24). The firm had revenue of $4.67 billion during the quarter, compared to analysts' expectations of $5.16 billion. Nutrien had a net margin of 2.05% and a return on equity of 6.08%. Nutrien's revenue was down 5.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.46 EPS.

NTR has been the topic of several other research reports. UBS Group lifted their price target on shares of Nutrien from $52.00 to $56.00 and gave the company a "neutral" rating in a report on Thursday, May 8th. TD Securities raised their target price on Nutrien from $64.00 to $67.00 and gave the company a "buy" rating in a research note on Monday, May 12th. Scotiabank lowered Nutrien from an "outperform" rating to a "sector perform" rating and set a $62.00 price target on the stock. in a research report on Thursday, May 22nd. BNP Paribas upgraded Nutrien to a "strong-buy" rating in a report on Wednesday, April 9th. Finally, The Goldman Sachs Group raised their price objective on Nutrien from $53.00 to $59.00 and gave the company a "sell" rating in a research report on Friday, May 9th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and an average target price of $62.12.

Nutrien Price Performance

NTR opened at $58.07 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.59 and a current ratio of 1.22. The stock has a market capitalization of $28.28 billion, a PE ratio of 54.27, a price-to-earnings-growth ratio of 1.11 and a beta of 0.81. The stock's 50 day moving average price is $58.22 and its 200-day moving average price is $52.78. Nutrien has a 52-week low of $43.70 and a 52-week high of $65.08.

Nutrien Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 18th. Shareholders of record on Monday, June 30th will be paid a dividend of $0.545 per share. The ex-dividend date is Monday, June 30th. This represents a $2.18 annualized dividend and a yield of 3.75%. Nutrien's dividend payout ratio is 203.74%.

Institutional Trading of Nutrien

A number of institutional investors and hedge funds have recently modified their holdings of NTR. Charles Schwab Investment Management Inc. boosted its position in shares of Nutrien by 8.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,886,376 shares of the company's stock valued at $84,367,000 after buying an additional 144,025 shares during the last quarter. Farther Finance Advisors LLC lifted its stake in Nutrien by 27.6% during the 1st quarter. Farther Finance Advisors LLC now owns 4,627 shares of the company's stock valued at $229,000 after acquiring an additional 1,002 shares during the period. Jackson Hole Capital Partners LLC boosted its holdings in shares of Nutrien by 5.4% during the 4th quarter. Jackson Hole Capital Partners LLC now owns 58,591 shares of the company's stock valued at $2,622,000 after acquiring an additional 2,997 shares during the last quarter. US Bancorp DE grew its stake in shares of Nutrien by 29.6% in the fourth quarter. US Bancorp DE now owns 30,549 shares of the company's stock worth $1,367,000 after acquiring an additional 6,975 shares during the period. Finally, Wealthfront Advisers LLC bought a new stake in shares of Nutrien in the fourth quarter worth approximately $556,000. Institutional investors own 63.10% of the company's stock.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.